Observe a variety of GI endoscopic procedures performed using Eleview® submucosal injection agent, including polypectomies, EMRs, and ESDs. Also watch Dr. Luigi Moro, CSO of Cosmo Pharmaceuticals, describe the components and functionality of Eleview®.

Explore the Eleview® video library

Polypectomy

Endoscopic Polypectomy with Eleview® at Biopsy Site

Endoscopic Polypectomy Performed Using Eleview®

Endoscopic mucosal resection

Endoscopic Mucosal Resection of the Transverse Colon with Eleview®

View transcript

Endoscopic Mucosal Resection of the Cecum with Eleview®

View transcript

Endoscopic Mucosal Resection of a Sessile Polyp with Eleview®

Endoscopic Mucosal Resection of the Ascending Colon Performed with Eleview®

Piecemeal Endoscopic Mucosal Resection with Eleview®

Endoscopic Mucosal Resection of a Laterally Spreading Tumor with Eleview®

Endoscopic Mucosal Resection of a 1.5 cm Sessile Serrated Cecal Polyp with Eleview®

Endoscopic submucosal dissection

Endoscopic Submucosal Dissection of the Sigmoid Colon Performed with Eleview®

Esophageal Endoscopic Submucosal Dissection with Eleview®

Back to Top

Composition

Eleview® composition described by Dr. Luigi Moro of Cosmo Pharmaceuticals

View transcript

Eleview® Demonstration and Mechanism of Action

View transcript

Dr. Luigi Moro discusses differences between two staining agents, methylene blue and indigo carmine

View transcript

Dr. Luigi Moro discusses the advantages of poloxamer 188, a component of Eleview®

View transcript

ASGE Tech Talk

Dr. Douglas Rex and Dr. Prateek Sharma discuss Eleview® as part of the ASGE Tech Talk

View transcript

Administration

Dr. Luigi Moro discusses the ease of use of Eleview® submucosal injection agent

View transcript

Margin Delineation

Margin Delineation of a Cecal Adenoma with Eleview®

Back to Top

INDICATIONS FOR USE

Eleview® submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.

CONTRAINDICATIONS

Patients with known sensitivity to any of the components contained in Eleview®.

WARNINGS AND PRECAUTIONS

  • The endoscopist injecting Eleview® must be experienced in the administration technique.
  • The safety of Eleview® has not been established in pregnant or lactating women, or in children under 18 years of age.
  • Eleview® is provided in single-use ampoules. Eleview® should not be reused after the first opening. Any emulsion not injected during the procedure should not be reused for another endoscopic procedure.
  • Do not use if the primary packaging (ampoule) or secondary packaging (aluminum pouch) is damaged.
  • Do not use if the twist-off cap is damaged.
  • Do not use if the emulsion is not clear, shows any signs of opalescence, or contains floating or precipitated visible particles.
  • The product compatibility with other substances has not been tested.

ADVERSE REACTIONS

Rarely, local bleeding and/or inflammatory reaction could occur which may or may not be associated with Eleview®.

DOSAGE AND ADMINISTRATION

The administered dose of Eleview® should be determined based on the dimensions of the lesion to be removed. Inject into the submucosa the amount of Eleview® needed to form a submucosal cushion of optimal height and shape for the lesion to be removed. During the procedure do not exceed a total dose of 50 mL per patient, either in single or in multiple administrations.

Please see Instructions for Use for complete Important Safety Information.